Insider Selling Momentum at SkyWater Technology

SkyWater’s Chief Financial Officer, Steve Manko, has sold 75 000 shares on 11 May 2026, taking the company’s insider holdings down to just 96 567 shares. The transaction, executed under a Rule 10b‑5‑1 trading plan, was priced at an average of $35.08—slightly above the current market close of $35.59. With a modest 0.02 % dip in the share price and a relatively low buzz score of 10.33 %, the sale appears to be a routine plan‑based move rather than a sign of impending distress.

What Investors Should Note

SkyWater’s share price is still on an upward trajectory, up 2 % in the week and almost 20 % over the month, driven by the high‑profile merger with IonQ. Manko’s sale, however, may raise questions about insider confidence. Historically, the CFO has alternated between buying and selling: a bulk purchase of 10 693 shares on 14 April, followed by a large 84 215‑share sale the same day at $30.41, and more modest trades in March. These mixed patterns suggest that Manko uses the 10b‑5‑1 plan to diversify his portfolio rather than to signal a negative view on the company’s prospects.

A Profile of Steve Manko

Manko has maintained a net insider position that has hovered in the 200‑300 k‑share range for the past year, with periodic sales that are often triggered by the plan’s pre‑set schedule. His transaction history shows a tendency to sell when the stock trades below $30, and to buy when it rises above $30. This counter‑cyclical approach implies a belief in the long‑term upside of SkyWater’s chip‑foundry and quantum‑hardware strategy, even if short‑term price fluctuations prompt portfolio rebalancing. The CFO’s recent sell of 75 000 shares—about 25 % of his holdings—aligns with this pattern and is unlikely to alter the company’s strategic trajectory.

Implications for the Future

Given SkyWater’s recent merger with IonQ and its strong fundamentals (PE 14.84, market cap $1.73 bn, 52‑week high $36.27), the CFO’s plan‑based sale should not be viewed as a warning sign. Instead, it is a routine rebalancing of a long‑term investment thesis. Investors who have followed the merger narrative may see the 75 000‑share sale as a normal event that will likely have minimal impact on the stock’s momentum. The key to watch will be whether the company continues to execute on its quantum‑chip integration roadmap and whether the market rewards the strategic partnership with IonQ in the coming quarters.

DateOwnerTransaction TypeSharesPrice per ShareSecurity
2026-05-11Manko Steve (CFO)Sell75,000.0035.08Common Stock